These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 22093189)

  • 1. Distribution and associations of [-2]proenzyme-prostate specific antigen in community dwelling black and white men.
    Rhodes T; Jacobson DJ; McGree ME; St Sauver JL; Sarma AV; Girman CJ; Lieber MM; Klee GG; Demissie K; Jacobsen SJ
    J Urol; 2012 Jan; 187(1):92-6. PubMed ID: 22093189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benign prostate specific antigen distribution and associations with urological outcomes in community dwelling black and white men.
    Rhodes T; Jacobson DJ; McGree ME; St Sauver JL; Sarma AV; Girman CJ; Lieber MM; Klee GG; Demissie K; Jacobsen SJ
    J Urol; 2012 Jan; 187(1):87-91. PubMed ID: 22093190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Associations between diabetes and clinical markers of benign prostatic hyperplasia among community-dwelling Black and White men.
    Sarma AV; Burke JP; Jacobson DJ; McGree ME; St Sauver J; Girman CJ; Lieber MM; Herman W; Macoska J; Montie JE; Jacobsen SJ
    Diabetes Care; 2008 Mar; 31(3):476-82. PubMed ID: 18071006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Age-specific distribution of serum prostate-specific antigen in a community-based study of African-American men.
    Cooney KA; Strawderman MS; Wojno KJ; Doerr KM; Taylor A; Alcser KH; Heeringa SG; Taylor JM; Wei JT; Montie JE; Schottenfeld D
    Urology; 2001 Jan; 57(1):91-6. PubMed ID: 11164150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Racial differences in longitudinal changes in serum prostate-specific antigen levels: the Olmsted County Study and the Flint Men's Health Study.
    Sarma AV; St Sauver JL; Jacobson DJ; McGree ME; Klee GG; Lieber MM; Girman CJ; Hollingsworth JM; Jacobsen SJ;
    Urology; 2014 Jan; 83(1):88-93. PubMed ID: 24139354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diabetes treatment and progression of benign prostatic hyperplasia in community-dwelling black and white men.
    Sarma AV; St Sauver JL; Hollingsworth JM; Jacobson DJ; McGree ME; Dunn RL; Lieber MM; Jacobsen SJ;
    Urology; 2012 Jan; 79(1):102-8. PubMed ID: 22112286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [-2]proenzyme prostate specific antigen for prostate cancer detection: a national cancer institute early detection research network validation study.
    Sokoll LJ; Wang Y; Feng Z; Kagan J; Partin AW; Sanda MG; Thompson IM; Chan DW
    J Urol; 2008 Aug; 180(2):539-43; discussion 543. PubMed ID: 18550118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of lower urinary tract symptom severity and associated bother between community-dwelling black and white men: the Olmsted County Study of Urinary Symptoms and Health Status and the Flint Men's Health Study.
    Sarma AV; Wei JT; Jacobson DJ; Dunn RL; Roberts RO; Girman CJ; Lieber MM; Cooney KA; Schottenfeld D; Montie JE; Jacobsen SJ; ;
    Urology; 2003 Jun; 61(6):1086-91. PubMed ID: 12809866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Prostate-Specific Antigen Velocity With Clinical Progression Among African American and Non-Hispanic White Men Treated for Low-Risk Prostate Cancer With Active Surveillance.
    Nelson TJ; Javier-DesLoges J; Deka R; Courtney PT; Nalawade V; Mell L; Murphy J; Parsons JK; Rose BS
    JAMA Netw Open; 2021 May; 4(5):e219452. PubMed ID: 33999164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential selection bias in a community-based study of PSA levels in African-American men.
    Heeringa SG; Alcser KH; Doerr K; Strawderman M; Cooney K; Medbery B; Schottenfeld D
    J Clin Epidemiol; 2001 Feb; 54(2):142-8. PubMed ID: 11166529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is PSA related to serum cholesterol and does the relationship differ between black and white men?
    Zapata D; Howard LE; Allott EH; Hamilton RJ; Goldberg K; Freedland SJ
    Prostate; 2015 Dec; 75(16):1877-85. PubMed ID: 26332663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostate specific antigen remains an independent predictor of cancer at prostate biopsy in black american men but not in white men: results from a consecutive series of 914 men.
    Latchamsetty KC; Kim J; Porter CR
    J Urol; 2006 Mar; 175(3 Pt 1):913-7; discussion 917. PubMed ID: 16469578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [-2]Proenzyme prostate specific antigen is more accurate than total and free prostate specific antigen in differentiating prostate cancer from benign disease in a prospective prostate cancer screening study.
    Le BV; Griffin CR; Loeb S; Carvalhal GF; Kan D; Baumann NA; Catalona WJ
    J Urol; 2010 Apr; 183(4):1355-9. PubMed ID: 20171670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current age and race adjusted prostate specific antigen threshold values delay diagnosis of high grade prostate cancer.
    Reed A; Ankerst DP; Pollock BH; Thompson IM; Parekh DJ
    J Urol; 2007 Nov; 178(5):1929-32; discussion 1932. PubMed ID: 17868724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Initial prostate specific antigen 1.5 ng/ml or greater in men 50 years old or younger predicts higher prostate cancer risk.
    Tang P; Sun L; Uhlman MA; Robertson CN; Polascik TJ; Albala DM; Donatucci CF; Moul JW
    J Urol; 2010 Mar; 183(3):946-50. PubMed ID: 20083275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Longitudinal changes in lower urinary tract symptoms among a cohort of black American men: the Flint Men's Health Study.
    Sarma AV; McLaughlin JC; Jacobsen SJ; Logie J; Dolin P; Dunn RL; Cooney KA; Montie JE; Schottenfeld D; Wei JT
    Urology; 2004 Nov; 64(5):959-65. PubMed ID: 15533486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Baseline Prostate-specific Antigen Level in Midlife and Aggressive Prostate Cancer in Black Men.
    Preston MA; Gerke T; Carlsson SV; Signorello L; Sjoberg DD; Markt SC; Kibel AS; Trinh QD; Steinwandel M; Blot W; Vickers AJ; Lilja H; Mucci LA; Wilson KM
    Eur Urol; 2019 Mar; 75(3):399-407. PubMed ID: 30237027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Racial differences in serum prostate-specific antigen (PSA) doubling time, histopathological variables and long-term PSA recurrence between African-American and white American men undergoing radical prostatectomy for clinically localized prostate cancer.
    Tewari A; Horninger W; Badani KK; Hasan M; Coon S; Crawford ED; Gamito EJ; Wei J; Taub D; Montie J; Porter C; Divine GW; Bartsch G; Menon M
    BJU Int; 2005 Jul; 96(1):29-33. PubMed ID: 15963115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Relationship of Baseline Prostate Specific Antigen and Risk of Future Prostate Cancer and Its Variance by Race.
    Verges DP; Dani H; Sterling WA; Weedon J; Atallah W; Mehta K; Schreiber D; Weiss JP; Karanikolas NT
    J Natl Med Assoc; 2017 Spring; 109(1):49-54. PubMed ID: 28259216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sixteen-year longitudinal changes in serum prostate-specific antigen levels: the olmsted county study.
    Jacobsen SJ; Jacobson DJ; McGree ME; St Sauver JL; Klee GG; Girman CJ; Lieber MM
    Mayo Clin Proc; 2012 Jan; 87(1):34-40. PubMed ID: 22212966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.